Analysis

Why Many Drugs Remain Pricey 40 Years After Hatch-Waxman

By Hannah Albarazi · September 27, 2024, 7:17 PM EDT

In the four decades since Congress passed the Hatch-Waxman Act in an effort to make generic drugs more available, the pharmaceutical industry has used patent thickets, "evergreening" and pay-for-delay tactics to...

To view the full article, register now.